| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.053 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |